mechanism glp 1 receptor agonist Glucagon-like peptide-1 receptor: mechanisms and advances in therapy PDB-101: Molecule of the Month:
Description
55:45 - Pre-Wegovy: The Education Challenge Sarah emphasizes this was long before Wegovy and Ozempic made GLP-1 common knowledge

Originally developed for the treatment of type 2 diabetes, these therapies have expanded into broader use for weight management, cardiometabolic risk reduction, and comprehensive metabolic care

doi: 10.1016/j.physbeh.2019.112771, 83 KreymannB.WilliamsG.GhateiM

More concerning is the amount of skeletal muscle loss from significant weight loss [4]

Orthostatic hypotension in older people: considerations, diagnosis and management

Reproductive goals change the risk-benefit equation entirely. When Weight Loss Is Not the Right Primary Goal Not everyone who wants a GLP-1 medication benefits from weight loss as the first intervention